nodes	percent_of_prediction	percent_of_DWPC	metapath
Mecamylamine—Fibrosis—Fluorouracil—pancreatic cancer	0.0757	0.0757	CcSEcCtD
Mecamylamine—Ileus—Erlotinib—pancreatic cancer	0.0447	0.0447	CcSEcCtD
Mecamylamine—Ileus—Irinotecan—pancreatic cancer	0.0319	0.0319	CcSEcCtD
Mecamylamine—Glossitis—Sunitinib—pancreatic cancer	0.0297	0.0297	CcSEcCtD
Mecamylamine—Pulmonary oedema—Sunitinib—pancreatic cancer	0.0244	0.0244	CcSEcCtD
Mecamylamine—Ileus—Docetaxel—pancreatic cancer	0.0221	0.0221	CcSEcCtD
Mecamylamine—Pulmonary oedema—Gemcitabine—pancreatic cancer	0.0196	0.0196	CcSEcCtD
Mecamylamine—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.0185	0.0185	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.015	0.015	CcSEcCtD
Mecamylamine—Ileus—Epirubicin—pancreatic cancer	0.0149	0.0149	CcSEcCtD
Mecamylamine—Pulmonary oedema—Docetaxel—pancreatic cancer	0.0139	0.0139	CcSEcCtD
Mecamylamine—Ileus—Doxorubicin—pancreatic cancer	0.0138	0.0138	CcSEcCtD
Mecamylamine—Syncope—Erlotinib—pancreatic cancer	0.0124	0.0124	CcSEcCtD
Mecamylamine—Loss of consciousness—Erlotinib—pancreatic cancer	0.0122	0.0122	CcSEcCtD
Mecamylamine—Glossitis—Epirubicin—pancreatic cancer	0.0114	0.0114	CcSEcCtD
Mecamylamine—Shock—Erlotinib—pancreatic cancer	0.0111	0.0111	CcSEcCtD
Mecamylamine—Anorexia—Tamoxifen—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Mecamylamine—Anorexia—Erlotinib—pancreatic cancer	0.0108	0.0108	CcSEcCtD
Mecamylamine—Glossitis—Doxorubicin—pancreatic cancer	0.0106	0.0106	CcSEcCtD
Mecamylamine—Convulsion—Sunitinib—pancreatic cancer	0.0104	0.0104	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.0103	0.0103	CcSEcCtD
Mecamylamine—Paraesthesia—Tamoxifen—pancreatic cancer	0.0103	0.0103	CcSEcCtD
Mecamylamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00993	0.00993	CcSEcCtD
Mecamylamine—Fatigue—Tamoxifen—pancreatic cancer	0.00984	0.00984	CcSEcCtD
Mecamylamine—Decreased appetite—Erlotinib—pancreatic cancer	0.00982	0.00982	CcSEcCtD
Mecamylamine—Constipation—Tamoxifen—pancreatic cancer	0.00976	0.00976	CcSEcCtD
Mecamylamine—Fatigue—Erlotinib—pancreatic cancer	0.00974	0.00974	CcSEcCtD
Mecamylamine—Constipation—Erlotinib—pancreatic cancer	0.00966	0.00966	CcSEcCtD
Mecamylamine—Shock—Sunitinib—pancreatic cancer	0.00962	0.00962	CcSEcCtD
Mecamylamine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00937	0.00937	CcSEcCtD
Mecamylamine—Anorexia—Sunitinib—pancreatic cancer	0.00932	0.00932	CcSEcCtD
Mecamylamine—Vision blurred—Fluorouracil—pancreatic cancer	0.00891	0.00891	CcSEcCtD
Mecamylamine—Syncope—Irinotecan—pancreatic cancer	0.00885	0.00885	CcSEcCtD
Mecamylamine—Paraesthesia—Sunitinib—pancreatic cancer	0.00878	0.00878	CcSEcCtD
Mecamylamine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00867	0.00867	CcSEcCtD
Mecamylamine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00867	0.00867	CcSEcCtD
Mecamylamine—Decreased appetite—Sunitinib—pancreatic cancer	0.0085	0.0085	CcSEcCtD
Mecamylamine—Fatigue—Sunitinib—pancreatic cancer	0.00843	0.00843	CcSEcCtD
Mecamylamine—Constipation—Sunitinib—pancreatic cancer	0.00836	0.00836	CcSEcCtD
Mecamylamine—Asthenia—Tamoxifen—pancreatic cancer	0.00819	0.00819	CcSEcCtD
Mecamylamine—Convulsion—Fluorouracil—pancreatic cancer	0.00819	0.00819	CcSEcCtD
Mecamylamine—Asthenia—Erlotinib—pancreatic cancer	0.0081	0.0081	CcSEcCtD
Mecamylamine—Shock—Irinotecan—pancreatic cancer	0.00792	0.00792	CcSEcCtD
Mecamylamine—Anorexia—Irinotecan—pancreatic cancer	0.00768	0.00768	CcSEcCtD
Mecamylamine—Dizziness—Tamoxifen—pancreatic cancer	0.00755	0.00755	CcSEcCtD
Mecamylamine—Anorexia—Gemcitabine—pancreatic cancer	0.00748	0.00748	CcSEcCtD
Mecamylamine—Dizziness—Erlotinib—pancreatic cancer	0.00747	0.00747	CcSEcCtD
Mecamylamine—Anorexia—Fluorouracil—pancreatic cancer	0.00735	0.00735	CcSEcCtD
Mecamylamine—Vomiting—Tamoxifen—pancreatic cancer	0.00726	0.00726	CcSEcCtD
Mecamylamine—Paraesthesia—Irinotecan—pancreatic cancer	0.00723	0.00723	CcSEcCtD
Mecamylamine—Vomiting—Erlotinib—pancreatic cancer	0.00718	0.00718	CcSEcCtD
Mecamylamine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00705	0.00705	CcSEcCtD
Mecamylamine—Asthenia—Sunitinib—pancreatic cancer	0.00702	0.00702	CcSEcCtD
Mecamylamine—Decreased appetite—Irinotecan—pancreatic cancer	0.007	0.007	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00698	0.00698	CcSEcCtD
Mecamylamine—Fatigue—Irinotecan—pancreatic cancer	0.00694	0.00694	CcSEcCtD
Mecamylamine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00693	0.00693	CcSEcCtD
Mecamylamine—Constipation—Irinotecan—pancreatic cancer	0.00689	0.00689	CcSEcCtD
Mecamylamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.00682	0.00682	CcSEcCtD
Mecamylamine—Nausea—Tamoxifen—pancreatic cancer	0.00678	0.00678	CcSEcCtD
Mecamylamine—Fatigue—Gemcitabine—pancreatic cancer	0.00676	0.00676	CcSEcCtD
Mecamylamine—Constipation—Gemcitabine—pancreatic cancer	0.00671	0.00671	CcSEcCtD
Mecamylamine—Nausea—Erlotinib—pancreatic cancer	0.00671	0.00671	CcSEcCtD
Mecamylamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.00671	0.00671	CcSEcCtD
Mecamylamine—Dizziness—Sunitinib—pancreatic cancer	0.00647	0.00647	CcSEcCtD
Mecamylamine—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00646	0.00646	CcSEcCtD
Mecamylamine—Vomiting—Sunitinib—pancreatic cancer	0.00622	0.00622	CcSEcCtD
Mecamylamine—Syncope—Docetaxel—pancreatic cancer	0.00612	0.00612	CcSEcCtD
Mecamylamine—Loss of consciousness—Docetaxel—pancreatic cancer	0.006	0.006	CcSEcCtD
Mecamylamine—Convulsion—Docetaxel—pancreatic cancer	0.00591	0.00591	CcSEcCtD
Mecamylamine—Nausea—Sunitinib—pancreatic cancer	0.00581	0.00581	CcSEcCtD
Mecamylamine—Asthenia—Irinotecan—pancreatic cancer	0.00578	0.00578	CcSEcCtD
Mecamylamine—Asthenia—Gemcitabine—pancreatic cancer	0.00563	0.00563	CcSEcCtD
Mecamylamine—Shock—Docetaxel—pancreatic cancer	0.00548	0.00548	CcSEcCtD
Mecamylamine—Dizziness—Irinotecan—pancreatic cancer	0.00533	0.00533	CcSEcCtD
Mecamylamine—Anorexia—Docetaxel—pancreatic cancer	0.00531	0.00531	CcSEcCtD
Mecamylamine—Vomiting—Irinotecan—pancreatic cancer	0.00512	0.00512	CcSEcCtD
Mecamylamine—Dizziness—Fluorouracil—pancreatic cancer	0.0051	0.0051	CcSEcCtD
Mecamylamine—Paraesthesia—Docetaxel—pancreatic cancer	0.005	0.005	CcSEcCtD
Mecamylamine—Vomiting—Gemcitabine—pancreatic cancer	0.00499	0.00499	CcSEcCtD
Mecamylamine—Vomiting—Fluorouracil—pancreatic cancer	0.00491	0.00491	CcSEcCtD
Mecamylamine—Decreased appetite—Docetaxel—pancreatic cancer	0.00484	0.00484	CcSEcCtD
Mecamylamine—Fatigue—Docetaxel—pancreatic cancer	0.0048	0.0048	CcSEcCtD
Mecamylamine—Nausea—Irinotecan—pancreatic cancer	0.00478	0.00478	CcSEcCtD
Mecamylamine—Constipation—Docetaxel—pancreatic cancer	0.00476	0.00476	CcSEcCtD
Mecamylamine—Nausea—Gemcitabine—pancreatic cancer	0.00466	0.00466	CcSEcCtD
Mecamylamine—Nausea—Fluorouracil—pancreatic cancer	0.00458	0.00458	CcSEcCtD
Mecamylamine—Vision blurred—Epirubicin—pancreatic cancer	0.00434	0.00434	CcSEcCtD
Mecamylamine—Syncope—Epirubicin—pancreatic cancer	0.00413	0.00413	CcSEcCtD
Mecamylamine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00404	0.00404	CcSEcCtD
Mecamylamine—Vision blurred—Doxorubicin—pancreatic cancer	0.00401	0.00401	CcSEcCtD
Mecamylamine—Asthenia—Docetaxel—pancreatic cancer	0.004	0.004	CcSEcCtD
Mecamylamine—Convulsion—Epirubicin—pancreatic cancer	0.00399	0.00399	CcSEcCtD
Mecamylamine—Syncope—Doxorubicin—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Mecamylamine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Mecamylamine—Shock—Epirubicin—pancreatic cancer	0.0037	0.0037	CcSEcCtD
Mecamylamine—Convulsion—Doxorubicin—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Mecamylamine—Dizziness—Docetaxel—pancreatic cancer	0.00368	0.00368	CcSEcCtD
Mecamylamine—Anorexia—Epirubicin—pancreatic cancer	0.00358	0.00358	CcSEcCtD
Mecamylamine—Vomiting—Docetaxel—pancreatic cancer	0.00354	0.00354	CcSEcCtD
Mecamylamine—Shock—Doxorubicin—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Mecamylamine—Paraesthesia—Epirubicin—pancreatic cancer	0.00337	0.00337	CcSEcCtD
Mecamylamine—Anorexia—Doxorubicin—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Mecamylamine—Nausea—Docetaxel—pancreatic cancer	0.00331	0.00331	CcSEcCtD
Mecamylamine—Decreased appetite—Epirubicin—pancreatic cancer	0.00326	0.00326	CcSEcCtD
Mecamylamine—Fatigue—Epirubicin—pancreatic cancer	0.00324	0.00324	CcSEcCtD
Mecamylamine—Constipation—Epirubicin—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Mecamylamine—Paraesthesia—Doxorubicin—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Mecamylamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.00302	0.00302	CcSEcCtD
Mecamylamine—Fatigue—Doxorubicin—pancreatic cancer	0.003	0.003	CcSEcCtD
Mecamylamine—Constipation—Doxorubicin—pancreatic cancer	0.00297	0.00297	CcSEcCtD
Mecamylamine—Asthenia—Epirubicin—pancreatic cancer	0.00269	0.00269	CcSEcCtD
Mecamylamine—Asthenia—Doxorubicin—pancreatic cancer	0.00249	0.00249	CcSEcCtD
Mecamylamine—Dizziness—Epirubicin—pancreatic cancer	0.00248	0.00248	CcSEcCtD
Mecamylamine—Vomiting—Epirubicin—pancreatic cancer	0.00239	0.00239	CcSEcCtD
Mecamylamine—Dizziness—Doxorubicin—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Mecamylamine—Nausea—Epirubicin—pancreatic cancer	0.00223	0.00223	CcSEcCtD
Mecamylamine—Vomiting—Doxorubicin—pancreatic cancer	0.00221	0.00221	CcSEcCtD
Mecamylamine—Nausea—Doxorubicin—pancreatic cancer	0.00206	0.00206	CcSEcCtD
